Bibliographic Info
GuidelineGuidelines for HIV post-exposure prophylaxis
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
Children. Dolutegravir (DTG) is recommended as the preferred third drug for HIV post-exposure prophylaxis with approved DTG dosing
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year2018
InstitutionWHO